- Home
- CAH vs CTVA Comparison
CAH vs CTVA Comparison
Compare CAH & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAH | CTVA |
|---|---|---|
| Founded | 1979 | 1802 |
| Country | United States | United States |
| Employees | N/A | 21500 |
| Industry | Other Pharmaceuticals | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.9B | 54.6B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CAH | CTVA |
|---|---|---|
| Price | $237.93 | $82.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $232.27 | $84.13 |
| AVG Volume (30 Days) | 2.1M | ★ 2.8M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.01% | 0.91% |
| EPS Growth | ★ 86.96 | 23.08 |
| EPS | ★ 1.88 | 1.07 |
| Revenue | ★ $222,578,000,000.00 | $17,401,000,000.00 |
| Revenue This Year | $17.36 | $6.09 |
| Revenue Next Year | $9.06 | $3.28 |
| P/E Ratio | $124.87 | ★ $76.18 |
| Revenue Growth | N/A | ★ 2.92 |
| 52 Week Low | $137.75 | $60.54 |
| 52 Week High | $237.79 | $85.63 |
Technical Indicators
Market Signals| Indicator | CAH | CTVA |
|---|---|---|
| Relative Strength Index (RSI) | 77.64 | 66.52 |
| Support Level | $196.64 | $77.96 |
| Resistance Level | N/A | $84.71 |
| Average True Range (ATR) | 6.01 | 1.71 |
| MACD | 1.83 | 0.78 |
| Stochastic Oscillator | 91.99 | 96.37 |
Price Performance
Historical ComparisonAbout CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in late 2026. The seeds business will be named Vylor, while the crop protection business will retain the Corteva name and be a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.